推荐应用
Ephrin-A4, also known as LERK-4 and EFL-4, is a member of the ephrin ligand family which binds members of the Eph receptor family. All ligands share a conserved extracellular sequence, which most likely corresponds to the receptor binding domain. This conserved sequence consists of approximately 125 amino acids and includes four invariant cysteines. The A-class ligands have a GPI anchor following the conserved sequence. Ephrin-A4 has been shown to bind EphA2, EphA3, EphA4, EphA5, EphA6, EphA7, and EphB1. The extracellular domains of human and mouse Ephrin-A4 share 80% amino acid identity. Only membrane-bound or Fc-clustered ligands are capable of activating the receptor in vitro. While soluble monomeric ligands bind the receptor, they do not induce receptor autophosphorylation and activation. In vivo, the ligands and receptors display reciprocal expression. It has been found that nearly all receptors and ligands are expressed in developing and adult neural tissue. The Eph/ephrin families also appear to play a role in angiogenesis.
高纯度、高活性、低内毒素、高批间一致性
产品数据

-25 ~ -15℃保存,收到货之后有效期1年。 复溶后, 无菌条件下,-85 ~ -65℃保存,3个月有效期。
【应用方向】HER2与HER3:ErbB受体家族协同靶向治疗的核心工具蛋白
115
2026-08-31
【应用方向】HER2:抗体药物研发的核心工具蛋白
112
2026-08-31
【应用方向】抗体药研发中常见靶点蛋白及其应用
154
2026-08-31
【应用方向】靶点蛋白在抗体药研发中的应用
114
2026-08-31
【应用方向】GPC3:HCC靶向治疗的核心靶点与药物研发探索
1875
2026-04-24
【应用方向】TROP2:从分子机制到实体瘤靶向治疗的研究进展
1849
2026-04-24
【应用方向】4-1BB-4-1BBL共刺激轴的T细胞活化机制
1117
2026-04-22
【应用方向】TNFR蛋白家族概述
1060
2026-04-21
【应用方向】Klotho蛋白:编织生命之线的抗衰老分子
1220
2026-04-20
【应用方向】药靶明星 | FGFRs家族蛋白解析
917
2026-04-20
【应用方向】解析Fc受体:抗体药物研发的核心靶点与评价基石
936
2026-04-20
【应用方向】FcγR家族:抗体药物研发的基石与核心靶点
992
2026-04-20
【应用方向】CD47-SIRPα轴研究工具与药物开发应用
841
2026-04-20
【技术讲解】ADC药物研究相关靶点汇总
19410
2025-07-30
【应用方向】抗体药筛选的关键—靶点蛋白
11619
2025-07-09





